Health Care • Biotechnology: Pharmaceutical Preparations
$83.18 ▲ +3.46
(+4.34%)
MKT CAP: $32.94B • VOL: 5.42M
52W L $69 52W H $145
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$70
MEDIAN
$93
MEAN
$95
HIGH
$113
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ZTS TAPE
ZTS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $100.65 | $95.66 | 2025-02-14 | $75.69 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $104.81 | $98.15 | 2025-02-06 | $78.19 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $94.83 | $91.50 | 2025-01-29 | $79.85 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $84.84 | — | 2025-01-17 | $81.52 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $73.20 | $79.02 | 2025-01-09 | $74.03 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $98.98 | $86.51 | 2024-12-18 | $72.37 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $80.68 | $84.01 | 2024-12-04 | $77.36 | -4.3% | 48% | C |